Borderline Personality Disorder Clinical Trial
Official title:
Study of Outcome With an Intervention From the Cape Cod Model of Psychotherapy for Subjects in a Behavioral Crisis and With the Diagnosis of Borderline Personality Disorder (BPD) or Post-Traumatic Stress Disorder (PTSD)
Dr. Laddis will test a hypothesis about the nature and the management of behavioral crises
in patients with borderline personality disorder (BPD) or post-traumatic stress disorder
(PTSD). The term "behavioral crisis" is used strictly for periods of uncontrollable urges to
repeat mental or outward activity, e.g., flashbacks, cutting, binging on food, drugs or sex,
with no intervals to rethink one's priorities or to consider others' direction.
The clinical hypothesis states, in two steps, that:
1. the perception of a life crisis precedes and then underlies every behavioral crisis;
2. the behavioral crisis resolves promptly and all symptoms end if the clinicians engage
the patient about his management of the life crisis that underlies the symptoms.
Subjects in the experimental group will be treated by Dr. Laddis after their admission to a
crisis stabilization unit (CSU) or to an inpatient unit (IPU) for a behavioral crisis.
Subjects will be included at random, as assigned to Dr. Laddis according to his routine
duties at those units.
Subjects in the control group will receive treatment for behavioral crisis according to the
preference of the clinical staff at other comparable units. That treatment will constitute
"treatment as usual". Clinicians in the control settings will not be informed about the
experimental hypothesis, the clinical intervention and the contingent outcomes.
The subjects will be tested for the results of treatment 12-24 hours after composition of a
treatment plan. The testing will be done with the Brief Psychiatric Rating Scale (BPRS), as
well as with a set of criteria devised by Dr. Laddis to measure the outward behavior and the
mental events during behavioral crisis. The patients and the attending frontline staff will
be interviewed also about their beliefs in regard to what, among the clinicians'
interventions, made a difference for the course of the behavioral crisis, for better or for
worse. The raters will be trained for interrater reliability and they will not be informed
about the hypothesis.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04856449 -
DBT Skills Plus EMDR for BPD and Trauma
|
N/A | |
Active, not recruiting |
NCT04587518 -
Five Factor Model Treatment for Borderline Personality Disorder
|
N/A | |
Recruiting |
NCT05651295 -
A Precision Medicine Approach to Target Engagement for Emotion Regulation
|
N/A | |
Completed |
NCT03677037 -
The Short-Term MBT Project
|
Phase 3 | |
Not yet recruiting |
NCT05989529 -
Delving Into Borderline Personality Disorder Clinical Trial Experiences
|
||
Completed |
NCT02068326 -
MBT in Groups for Adolescents With BPD or Subthreshold BPD Versus TAU - the M-GAB Randomized Controlled Trial
|
N/A | |
Completed |
NCT02518906 -
Evaluation of AIT Study
|
N/A | |
Recruiting |
NCT04296604 -
Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations
|
N/A | |
Terminated |
NCT02149823 -
Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations
|
Phase 1 | |
Completed |
NCT02108990 -
Acetaminophen and Social Processes
|
Phase 2 | |
Not yet recruiting |
NCT01683136 -
Evaluation of the HBDL Coil Transcranial Magnetic Stimulation (TMS) Device - Feasibility Study for the Treatment of Borderline Personality Disorder
|
N/A | |
Completed |
NCT02988037 -
Adapted Dialectical Behaviour Therapy for Adolescents With Deliberate Self-Harm: A Pre-post Observational Study
|
N/A | |
Completed |
NCT01635556 -
Evaluation of a Modified Dialectical Behavior Therapy Program
|
N/A | |
Completed |
NCT02397031 -
Mindfulness and Interpersonal Effectiveness Skills in Borderline Personality Disorder
|
N/A | |
Terminated |
NCT01103180 -
Selective Serotonin Reuptake Inhibitors (SSRIs) in Borderline Personality Disorder
|
Phase 2 | |
Terminated |
NCT01212588 -
Preliminary Trial of the Effect of Glucocorticoid Receptor Antagonist on Borderline Personality Disorder (BPD)
|
Phase 2 | |
Terminated |
NCT00539188 -
N-Acetylcysteine in Adjunct to DBT for the Treatment of Self-Injurious Behavior in BPD
|
Phase 2 | |
Recruiting |
NCT05398627 -
Neurofeedback for Borderline Personality Disorder
|
N/A | |
Recruiting |
NCT03994510 -
SHame prOpensity in bOrderline Personality Disorder
|
N/A | |
Recruiting |
NCT06005129 -
Personality Change Study for Borderline Personality Disorder
|
N/A |